Clincosm LogoSign in Get a demo

glioblastoma

Showing NaN - NaN of 56
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)

Not yet recruiting
  • High Grade Glioma
  • +8 more
  • Aurora, Colorado
  • +17 more
May 2, 2023

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

    Recruiting
    • Anaplastic Astrocytoma
    • +6 more
    • Biopsy
    • +3 more
    • Birmingham, Alabama
    • +62 more
    Feb 2, 2023

    Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

    Recruiting
    • Astrocytoma, Grade IV
    • +3 more
    • CYNK-001 systemic and Intra cavity administration
    • Duarte, California
    • +5 more
    Jan 20, 2023

    Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma Trial in United States (ribociclib, Everolimus)

    Completed
    • Diffuse Intrinsic Pontine Glioma
    • +6 more
    • Washington, District of Columbia
    • +6 more
    Jan 12, 2023

    Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

    Active, not recruiting
    • Anaplastic Astrocytoma
    • +2 more
    • Radiation Therapy
    • +2 more
    • Birmingham, Alabama
    • +162 more
    Dec 30, 2022

    Glioblastoma Trial in United States (Abemaciclib, Surgery)

    Active, not recruiting
    • Glioblastoma
    • Los Angeles, California
    • +6 more
    Dec 28, 2022

    Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

    Recruiting
    • Advanced Solid Tumors
    • +11 more
    • Boston, Massachusetts
    • +4 more
    Dec 12, 2022

    Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

    Recruiting
    • Anaplastic Astrocytoma, IDH-Wildtype
    • +8 more
    • Quality-of-Life Assessment
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 8, 2022

    Glioblastoma Trial in Canada, China, United States (drug, other, radiation)

    Active, not recruiting
    • Glioblastoma
    • Enzastaurin Hydrochloride
    • +3 more
    • Birmingham, Alabama
    • +62 more
    Oct 11, 2022

    Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

    Terminated
    • Glioma
    • +23 more
    • Tucson, Arizona
    • +11 more
    Sep 30, 2022

    Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)

    Recruiting
    • Glioblastoma
    • Gliosarcoma
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 27, 2022

    Advanced Malignant Solid Tumor, Glioblastoma, Recurrent Cholangiocarcinoma Trial in United States (Olaparib)

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +6 more
    • Costa Mesa, California
    • +49 more
    Aug 24, 2022

    Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

    Recruiting
    • Mesothelioma
    • +14 more
    • Los Angeles, California
    • +13 more
    Aug 16, 2022

    Glioblastoma Trial in United States (Temozolomide, Neratinib, QBS10072S)

    Active, not recruiting
    • Glioblastoma
    • Birmingham, Alabama
    • +11 more
    Aug 15, 2022

    Glioblastoma Trial in United States (biological, radiation, drug)

    Active, not recruiting
    • Glioblastoma
    • INO-5401
    • +4 more
    • Duarte, California
    • +20 more
    Aug 8, 2022

    Glioblastoma, Adult-type Diffuse Gliomas Trial in Worldwide (Pemigatinib)

    Recruiting
    • Glioblastoma
    • Adult-type Diffuse Gliomas
    • Beverly Hills, California
    • +83 more
    Jul 25, 2022

    Glioblastoma Trial in Camden, Houston (TH-1 Dendritic Cell Immunotherapy)

    Recruiting
    • Glioblastoma
    • TH-1 Dendritic Cell Immunotherapy
    • Camden, New Jersey
    • +1 more
    Jun 27, 2022

    Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

    Active, not recruiting
    • Glioblastoma Multiforme
    • +6 more
    • Dendritic cell immunotherapy
    • Birmingham, Alabama
    • +85 more
    May 12, 2022

    Glioblastoma Trial in Worldwide (DSP-7888 Dosing Emulsion, Bevacizumab)

    Active, not recruiting
    • Glioblastoma
    • Birmingham, Alabama
    • +60 more
    Apr 4, 2022

    Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

    Active, not recruiting
    • Glioma
    • +4 more
    • VAL-083, Dianhydrogalactitol
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Mar 23, 2022

    Solid Tumor, Glioblastoma, NSCLC Trial in Nashville, Houston, Villejuif (TAS2940)

    Recruiting
    • Solid Tumor
    • +3 more
    • Nashville, Tennessee
    • +2 more
    Feb 25, 2022

    Brain Metastases, Cancer, Gliomas Trial in Houston (F18 Fluciclovine, Standard of Care)

    Not yet recruiting
    • Brain Metastases
    • +3 more
    • F18 Fluciclovine
    • Standard of Care
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 11, 2022

    Glioblastoma, Low Grade Glioma, Malignant Glioma Trial in Houston (Mind-Body Intervention Procedure, Quality-of-Life Assessment,

    Completed
    • Glioblastoma
    • +5 more
    • Mind-Body Intervention Procedure
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 8, 2021

    Glioblastoma Trial in United States (Ad-RTS-hIL-12, veledimex, Nivolumab)

    Completed
    • Glioblastoma
    • Ad-RTS-hIL-12
    • +2 more
    • Chicago, Illinois
    • +3 more
    Oct 1, 2021